During the past decade, Barts Cancer Institute conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 3 clinical trials were completed, i.e. on average, 18.8% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Barts Cancer Institute" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Celgene" with 4 trials sponsored, "MedSIR" with 2 trials sponsored, "Genentech, Inc." with 1 trials sponsored and "Ipsen" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Barts Cancer Institute" #1 collaborator was "Barts Cancer Institute" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Churchill Hospital" with 1 trials as a collaborator, "Fundación Instituto Valenciano de Oncología" with 1 trials as a collaborator and "Hospital Universitari Vall d'Hebron Research Institute" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Barts Cancer Institute" are "Breast Cancer" (3 trials), "Metastatic Breast Cancer" (2 trials), "Advanced Breast Cancer" (1 trials), "Advanced Renal Cell Carcinoma (aRCC)" (1 trials) and "Anemia" (1 trials). Many other conditions were trialed in "Barts Cancer Institute" in a lesser frequency.

Most popular intervention types in "Barts Cancer Institute" are "Drug" (15 trials), "Other" (5 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (5 trials), "Placebo" (4 trials), "Lenalidomide" (3 trials), "Carboplatin" (2 trials) and "Docetaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Barts Cancer Institute" are 17 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Barts Cancer Institute". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Barts Cancer Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Barts Cancer Institute, 6 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".

Barts Cancer Institute has several departments that took part in Clinical trials: "Centre for Experimental Cancer Medicine (CECM)" - 2 trials